Clinical Trials Directory

Trials / Unknown

UnknownNCT02903043

Expression of miR-204 and Consequences on Capillarization in Limb Muscles of Patients With COPD

Expression of miR-204 and Consequences on Capillarization in Limb Muscles of Patients With Chronic Obstructive Pulmonary Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Laval University · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Accepted

Summary

Limb muscle dysfunction, characterized by loss of capillaries, is amongst the most troublesome systemic consequences of chronic obstructive pulmonary disease (COPD) leading to poor functional status and premature mortality. One prevailing hypothesis stipulates that modification in the expression of miR-204 leads to change the regulation of angiogenesis in vastus lateralis of patients with COPD when compared to controls.

Detailed description

The investigators objective is to investigate the impact of COPD on key signaling pathways involved in the muscle angiogenesis. Mild to severe COPD patients and healthy controls will be recruited. All of the investigators patients will undergo a thorough baseline assessment in pulmonary capacity and body composition. Blood sampling and biopsy of the quadriceps will be done. Key proteins and microRNAs of signaling intramuscular pathways involved in angiogenesis will be measured in the quadriceps.

Conditions

Timeline

Start date
2013-02-01
Primary completion
2015-04-01
Completion
2018-02-01
First posted
2016-09-16
Last updated
2017-05-10

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02903043. Inclusion in this directory is not an endorsement.